What Foundation Medicine, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Borisy Alexis | Director | Jul 31 | Tender Offer · U | −73,173 | $137.00 | −$10M | 0 |
| Cox Troy | President and CEO | Jul 31 | Other Transaction · J | −206,847 | $137.00 | −$28.3M | 0 |
| Cox Troy | President and CEO | Jul 31 | Tender Offer · U | −35,221 | $137.00 | −$4.83M | 206,847 |
| Civik Thomas | Chief Commercial Officer | Jul 31 | Other Transaction · J | −33,421 | $137.00 | −$4.58M | 0 |
| Ryan Jason | Chief Financial Officer | Jul 31 | Other Transaction · J | −42,215 | $137.00 | −$5.78M | 0 |
| Ryan Jason | Chief Financial Officer | Jul 31 | Tender Offer · U | −6,955 | $137.00 | −$953K | 42,215 |
| Yeshwant Krishna | Director | Jul 31 | Tender Offer · U | −5,786 | $137.00 | −$793K | 0 |
| Jones EVAN/ Fa | Director | Jul 31 | Tender Offer · U | −9,300 | $137.00 | −$1.27M | 0 |
| Jones EVAN/ Fa | Director | Jul 31 | Tender Offer · U | −17,652 | $137.00 | −$2.42M | 0 |
| Roche Holdings Inc | Director | Jul 31 | Open-market buy · P | +2,343,078 | $137.00 | +$321M | 36,825,315 |
| Roche Holdings Inc | Director | Jul 31 | Open-market buy · P | +13,877,949 | $137.00 | +$1.9B | 34,482,237 |
| Miller Vincent A. | Chief Medical Officer | Jul 31 | Other Transaction · J | −36,186 | $137.00 | −$4.96M | 0 |
| Miller Vincent A. | Chief Medical Officer | Jul 31 | Tender Offer · U | −30,993 | $137.00 | −$4.25M | 36,186 |
| Doherty Michael J | Head of Product Development | Jul 31 | Other Transaction · J | −65,332 | $137.00 | −$8.95M | 0 |
| Doherty Michael J | Head of Product Development | Jul 31 | Tender Offer · U | −15,955 | $137.00 | −$2.19M | 65,332 |
| Fiedler Konstantin | Chief Operating Officer | Jul 31 | Other Transaction · J | −23,582 | $137.00 | −$3.23M | 0 |
| Fiedler Konstantin | Chief Operating Officer | Jul 31 | Tender Offer · U | −3,253 | $137.00 | −$446K | 23,582 |
| Dougherty Michael R | Director | Jul 31 | Other Transaction · J | −12,669 | $137.00 | −$1.74M | 0 |
| Dougherty Michael R | Director | Jul 31 | Tender Offer · U | −12,120 | $137.00 | −$1.66M | 12,669 |
| Pellini Michael J | Director | Jul 31 | Tender Offer · U | −103,711 | $137.00 | −$14.2M | 0 |
Loading...
